World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
119
Citations
75159
World Ranking
336
National Ranking
211

Medicine

D-Index
120
Citations
77103
World Ranking
3672
National Ranking
2022

David L. Thomas publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David L. Thomas sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 643 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

David L. Thomas D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David L. Thomas sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 119 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 1994 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

David L. Thomas is affiliated with Johns Hopkins University in the United States. Their research focuses primarily on the field of medicine, with significant contributions in epidemiology, hepatology, infectious diseases, neurology, and general health professions.

The main topics covered in their work include:

  • Hepatitis C virus research
  • Hepatitis B virus studies
  • Liver disease diagnosis and treatment
  • HIV, drug use, sexual risk
  • COVID-19 clinical research studies
  • HIV/AIDS research and interventions
  • SARS-CoV-2 detection and testing

David L. Thomas has published extensively, with recent papers such as:

  • "COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva" (2020, Journal of Clinical Microbiology)
  • "Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations - United States, 2023" (2023, MMWR Recommendations and Reports)
  • "Detecting Liver Cancer Using Cell-Free DNA Fragmentomes" (2022, Cancer Discovery)
  • "Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019" (2020, Clinical Infectious Diseases)
  • "COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva" (2020, bioRxiv [Cold Spring Harbor Laboratory])

Their frequent coauthors include:

  • Shruti H. Mehta
  • Yukari C. Manabe
  • Gregory D. Kirk
  • Andrea L. Cox
  • Annukka A.R. Antar

David L. Thomas has contributed to numerous publications appearing in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Open Forum Infectious Diseases
  • Journal of Viral Hepatitis
  • The Journal of Infectious Diseases

In recognition of their scientific contributions, they were named a Fellow of the American Association for the Advancement of Science (AAAS) in 1994.

Best Publications

  • Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

    Richard K. Sterling;Eduardo Lissen;Eduardo Lissen;Nathan Clumeck;Ricard Sola

  • Diagnosis, management, and treatment of hepatitis C: An update

    Marc G. Ghany;Doris B. Strader;David L. Thomas;Leonard B. Seeff

  • Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

    David L. Thomas;Chloe L Thio;Maureen P. Martin;Ying Qi

  • Diagnosis, Management, and Treatment of Hepatitis C

    Doris B. Strader;Teresa Wright;Teresa Wright;David L. Thomas;Leonard B. Seeff;Leonard B. Seeff

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy

  • Multimodal population brain imaging in the UK Biobank prospective epidemiological study

    Karla L Miller;Fidel Alfaro-Almagro;Neal K Bangerter;David L Thomas

  • Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial

    Jörg Ederle;Joanna Dobson;Joanna Dobson;Roland L. Featherstone;Leo H. Bonati;Leo H. Bonati

  • An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases

    Marc G. Ghany;David R. Nelson;Doris B. Strader;David L. Thomas

  • The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors

    David L. Thomas;Jacquie Astemborski;Rudra M. Rai;Frank A. Anania

  • HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection

    Salim I. Khakoo;Chloe L. Thio;Maureen P. Martin;Collin R. Brooks

  • HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)

    Chloe L Thio;Eric C Seaberg;Richard Skolasky;John Phair

  • Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.

    Mark S. Sulkowski;David L. Thomas;Richard E. Chaisson;Richard D. Moore

  • Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

    Shruti H. Mehta;Frederick L. Brancati;Mark S. Sulkowski;Steffanie A. Strathdee

  • A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

    Ludmila Prokunina-Olsson;Brian Muchmore;Wei Tang;Ruth M Pfeiffer

  • Deployment of convalescent plasma for the prevention and treatment of COVID-19.

    Evan M. Bloch;Shmuel Shoham;Arturo Casadevall;Bruce S. Sachais

  • Severe Community-Onset Pneumonia in Healthy Adults Caused by Methicillin-Resistant Staphylococcus aureus Carrying the Panton-Valentine Leukocidin Genes

    John S. Francis;Meg C. Doherty;Uri Lopatin;Cecilia P. Johnston

  • Measuring cerebral blood flow using magnetic resonance imaging techniques

    Fernando Calamante;David L. Thomas;Gaby S. Pell;Jonna Wiersma

  • Occult hepatitis B

    Michael Torbenson;David L Thomas

  • Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.

    Mark S. Sulkowski;David L. Thomas;David L. Thomas;Shruti H. Mehta;Richard E. Chaisson

  • Persistence of Viremia and the Importance of Long Term Follow-up after Acute Hepatitis C Infection

    Stephen A. Villano;David Vlahov;Kenrad E. Nelson;Sylvia Cohn

Frequent Co-Authors

Shruti H. Mehta
Shruti H. Mehta Johns Hopkins University
Mark S. Sulkowski
Mark S. Sulkowski Johns Hopkins University School of Medicine
David Vlahov
David Vlahov Yale University
Jacquie Astemborski
Jacquie Astemborski Johns Hopkins University
Sebastien Ourselin
Sebastien Ourselin King's College London
Nick C. Fox
Nick C. Fox University College London
Chloe L. Thio
Chloe L. Thio Johns Hopkins University
Stuart C. Ray
Stuart C. Ray Johns Hopkins University School of Medicine
Gregory D. Kirk
Gregory D. Kirk Johns Hopkins University
Thomas C. Quinn
Thomas C. Quinn Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to diverse career paths, especially in healthcare and research. For those interested in clinical practice, pursuing advanced nursing degrees like the Psychiatric-Mental Health Nurse Practitioner (PMHNP) can complement immunology knowledge. Exploring top pmhnp programs helps identify quality online options with strong clinical placement rates, ensuring hands-on experience alongside academic study.

Cost is a significant consideration when choosing an online program. Many students seek affordable options that don't sacrifice quality. Checking out the cheapest pmhnp certificate programs can provide a budget-friendly pathway without compromising educational outcomes.

Career growth and earning potential are also crucial factors. Understanding dnp salary transparency allows prospective students and professionals to make informed decisions based on regional salary variations for Doctor of Nursing Practice graduates.

For nurses aiming to advance their specialization, transitioning from a Family Nurse Practitioner to an Acute Care Nurse Practitioner is a common route. Guidance on this career move can be found in resources about fnp to acute care np, highlighting necessary steps and additional certifications.

Best Scientists Citing David L. Thomas

Trending Scientists

Recently Published Articles